Understanding the Role of Endothelial Progenitor Cells in Percutaneous Coronary Intervention

Journal of the American College of Cardiology

Volumn 55, Issue 15, 2010, Pages 1553-1565

  Padfield, Gareth J ^a   Newby, David E ^a   Mills, Nicholas L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

angioplasty; endothelial progenitor cells; restenosis; stenting; vascular injury

Indexed keywords

ERYTHROPOIETIN; ESTROGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

BLOOD VESSEL INJURY; BONE MARROW; CELL CULTURE; CELL FUNCTION; CELL THERAPY; DRUG ACTIVITY; ENDOTHELIUM CELL; HUMAN; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; STEM CELL; STENT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CORONARY RESTENOSIS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; HUMANS; INTRAOPERATIVE PERIOD; STEM CELLS;

EID: 77950328512     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.10.070     Document Type: Review

References (119)

1. Risau W. Differentiation of endothelium. FASEB J 9 (1995) 926 3
2. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-966
3. Shi Q., Rafii S., Wu M.H.-D., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 (1998) 362-367
4. Mauri L., Silbaugh T.S., Wolf R.E., et al. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation 118 (2008) 1817-1827
5. de la Torre-Hernandez J.M., Alfonso F., Hernandez F., et al. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol 51 (2008) 986-990
6. Farb A., Sangiorgi G., Carter A.J., et al. Pathology of acute and chronic coronary stenting in humans. Circulation 99 (1999) 44-52
7. Mak K.H., Belli G., Ellis S.G., and Moliterno D.J. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol 27 (1996) 494-503
8. Mills N.L., Tura O., Padfield G.J., et al. Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary intervention. Heart 95 (2009) 2003-2008
9. Wilcox J.N., Okamoto E.I., Nakahara K.I., et al. Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors?. Ann N Y Acad Sci 947 (2001) 68-90
10. Grewe P.H., Deneke T., Holt S.K., et al. [Scanning electron microscopic analysis of vessel wall reactions after coronary stenting]. Z Kardiol 89 (2000) 21-27
11. Kipshidze N., Dangas G., Tsapenko M., et al. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 44 (2004) 733-739
12. Quaini F., Urbanek K., Beltrami A.P., et al. Chimerism of the transplanted heart. N Engl J Med 346 (2002) 5-15
13. Suratt B.T., Cool C.D., Serls A.E., et al. Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med 168 (2003) 318-322
14. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) 1e-7e
15. Fadini G.P., Miorin M., Facco M., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45 (2005) 1449-1457
16. Pirro M., Schillaci G., Menecali C., et al. Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. J Hypertens 25 (2007) 2093-2099
17. Chironi G., Walch L., Pernollet M.G., et al. Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis 191 (2007) 115-120
18. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
19. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005) 2981-2987
20. Thum T., Hoeber S., Froese S., et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 100 (2007) 434-443
21. Pelliccia F., Pasceri V., Meoni G., et al. Numbers of endothelial progenitor cells in peripheral blood are similar in younger and older patients with coronary artery disease. Int J Cardiol 133 (2009) 277-279
22. Whittaker A., Moore J.S., Vasa-Nicotera M., et al. Evidence for genetic regulation of endothelial progenitor cells and their role as biological markers of atherosclerotic susceptibility. Eur Heart J 29 (2008) 332-338
23. Dignat-George F., and Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 65 (2000) 215-220
24. Grisar J., Aletaha D., Steiner C.W., et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 111 (2005) 204-211
25. Gill M., Dias S., Hattori K., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2+AC133+ endothelial precursor cells. Circ Res 88 (2001) 167-174
26. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
27. Timmermans F., Van Hauwermeiren F., De Smedt M., et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 27 (2007) 1572-1579
28. Case J., Mead L.E., Bessler W.K., et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 35 (2007) 1109-1118
29. Wright S.D., Ramos R.A., Tobias P.S., et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
30. Fernandez Pujol B., Lucibello F.C., Gehling U.M., et al. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65 (2000) 287-300
31. Harraz M., Jiao C., Hanlon H.D., et al. CD34- Blood-derived human endothelial cell progenitors. Stem Cells 19 (2001) 304-312
32. Rehman J., Li J., Orschell C.M., et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
33. Schmeisser A., Garlichs C.D., Zhang H., et al. Monocytes co-express endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel(R) under angiogenic conditions. Cardiovasc Res 49 (2001) 671-680
34. Urbich C., Heeschen C., Aicher A., et al. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108 (2003) 2511-2516
35. Zhao Y., Glesne D., and Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 100 (2003) 2426-2431
36. Rohde E., Bartmann C., Schallmoser K., et al. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells 25 (2007) 1746-1752
37. Yoder M.C., Mead L.E., Prater D., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109 (2007) 1801-1809
38. Zhang S.J., Zhang H., Wei Y.J., et al. Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Cell Res 16 (2006) 577-584
39. Elsheikh E., Uzunel M., He Z., Holgersson J., Nowak G., and Sumitran-Holgersson S. Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity. Blood 106 (2005) 2347-2355
40. Fujiyama S., Amano K., Uehira K., et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 93 (2003) 980-989
41. Nowak G., Karrar A., Holmen C., et al. Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization. Circulation 110 (2004) 3699-3707
42. Hill J.M., Zalos G., Halcox J.P.J., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
43. Rohde E., Malischnik C., Thaler D., et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells 24 (2006) 357-367
44. Hur J., Yang H.M., Yoon C.H., et al. Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation 116 (2007) 1671-1682
45. Heeschen C., Lehmann R., Honold J., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109 (2004) 1615-1622
46. Loomans C.J., de Koning E.J., Staal F.J., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53 (2004) 195-199
47. Delva P., Degan M., Vallerio P., et al. Endothelial progenitor cells in patients with essential hypertension. J Hypertens 25 (2007) 127-132
48. Bonello L., Basire A., Sabatier F., et al. Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease. J Thromb Haemost 4 (2006) 979-981
49. Marboeuf P., Corseaux D., Mouquet F., et al. Inflammation triggers colony forming endothelial cell mobilization after angioplasty in chronic lower limb ischemia. J Thromb Haemost 6 (2008) 195-197
50. Banerjee S., Brilakis E., Zhang S., et al. Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis 189 (2006) 70-75
51. Garg R., Tellez A., Alviar C., et al. The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment. Catheter Cardiovasc Interv 72 (2008) 205-209
52. Ingram D.A., Mead L.E., Tanaka H., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104 (2004) 2752-2760
53. Lin Y., Weisdorf D.J., Solovey A., et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105 (2000) 71-77
54. Gulati R., Jevremovic D., Peterson T.E., et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93 (2003) 1023-1025
55. Ingram D.A., Mead L.E., Tanaka H., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104 (2004) 2752-2760
56. Massa M., Campanelli R., Bonetti E., et al. Rapid and large increase of the frequency of circulating endothelial colony-forming cells (ECFCs) generating late outgrowth endothelial cells in patients with acute myocardial infarction. Exp Hematol 37 (2009) 8-9
57. Huang L., Hou D., Thompson M.A., et al. Acute myocardial infarction in swine rapidly and selectively releases highly proliferative endothelial colony forming cells (ECFCs) into circulation. Cell Transplant 16 (2007) 887-897
58. Guven H., Shepherd R.M., Bach R.G., et al. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 48 (2006) 1579-1587
59. Martin-Rendon E., B S., Doree C., et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 24 (2008) CD006536
60. Yoshioka T., Takahashi M., Shiba Y., et al. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res 70 (2006) 61-69
61. Kong D., Melo L.G., Gnecchi M., et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110 (2004) 2039-2046
62. Werner N., Junk S., Laufs U., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93 (2003) 17e-24e
63. Werner N., Priller J., Laufs U., et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 22 (2002) 1567-1572
64. Takamiya M., Okigaki M., Jin D., et al. Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+ Progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 26 (2006) 751-757
65. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
66. George J., Herz I., Goldstein E., et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 23 (2003) 57e-60e
67. Lei L.C., Huo Y., Li J.P., et al. [Activities of circulating endothelial progenitor cells in patients with in-stent restenosis]. Zhonghua Yi Xue Za Zhi 87 (2007) 3394-3398
68. Matsuo Y., Imanishi T., Hayashi Y., et al. The effect of senescence of endothelial progenitor cells on in-stent restenosis in patients undergoing coronary stenting. Intern Med 45 (2006) 581-587
69. Lee L.C., Chen C.S., Choong P.F., Low A., Tan H.c., and Poh K.K. Time-dependent dynamic mobilization of circulating progenitor cells during percutaneous coronary intervention in diabetics. Int J Cardiol (2009 Jan 19) [Epub ahead of print]
70. Thomas H., Avery P., Ahmed J., et al. Local vessel injury following PCI does not promote early mobilisation of endothelial progenitor cells in the absence of myocardial necrosis. Heart 95 (2008) 555-558
71. Thomas H.E., Redgrave R., Cunnington M.S., et al. Circulating endothelial progenitor cells exhibit diurnal variation. Arterioscler Thromb Vasc Biol 28 (2008) e21-e22
72. Egan C.G., Caporali F., Huqi A.F., et al. Reduced levels of putative endothelial progenitor and CXCR4+ cells in coronary artery disease: kinetics following percutaneous coronary intervention and association with clinical characteristics. Thromb Haemost 101 (2009) 1138-1146
73. Schober A., Hoffmann R., Opree N., et al. Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease. Am J Cardiol 96 (2005) 1116-1122
74. Inoue T., Sata M., Hikichi Y., et al. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation 115 (2007) 553-561
75. Muldowney III J.A., Stringham J.R., Levy S.E., et al. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents. Arterioscler Thromb Vasc Biol 27 (2007) 400-406
76. Wojakowski W., Kucia M., Kazmierski M., et al. Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism?. Heart 94 (2008) 27-33
77. Aicher A., Zeiher A.M., and Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 45 (2005) 321-325
78. Heissig B., Hattori K., Dias S., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109 (2002) 625-637
79. Huang P.L. eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab 20 (2009) 295-302
80. Thum T., Fraccarollo D., Schultheiss M., et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56 (2007) 666-674
81. Sasaki K., Heeschen C., Aicher A., et al. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci U S A 103 (2006) 14537-14541
82. Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
83. Leone A.M., Rutella S., Giannico M.B., et al. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. Int J Cardiol 130 (2008) 457-462
84. Llevadot J., Murasawa S., Kureishi Y., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108 (2001) 399-405
85. Deschaseaux F., Selmani Z., Falcoz P.E., et al. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors. Eur J Pharmacol 562 (2007) 111-118
86. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108 (2001) 391-397
87. Fukuda D., Enomoto S., Shirakawa I., et al. Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatment. Eur J Pharmacol 612 (2009) 87-92
88. Walter D.H., Schachinger V., Elsner M., et al. Effect of statin therapy on restenosis after coronary stent implantation. Am J Cardiol 85 (2000) 962-968
89. Korbling M., Reuben J.M., Gao H., et al. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis. Transfusion 46 (2006) 1795-1802
90. Powell T.M., Paul J.D., Hill J.M., et al. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25 (2005) 296-301
91. Shi Q., Bhattacharya V., Hong-De Wu M., et al. Utilizing granulocyte colony-stimulating factor to enhance vascular graft endothelialization from circulating blood cells. Ann Vasc Surg 16 (2002) 314-320
92. Ziegelhoeffer T., Fernandez B., Kostin S., et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94 (2004) 230-238
93. Gulati R., Jevremovic D., Peterson T.E., et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 108 (2003) 1520-1526
94. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
95. Kang S., Yang Y., Li C., et al. Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis 19 (2004) 327-335
96. Wang C.H., Ciliberti N., Li S.H., et al. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 109 (2004) 1392-1400
97. Singh S., Loke Y.K., and Furberg C.D. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA 298 (2007) 1189-1195
98. Urao N., Okigaki M., Yamada H., et al. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98 (2006) 1405-1413
99. Reddy M.K., Vasir J.K., Hegde G.V., et al. Erythropoietin induces excessive neointima formation: a study in a rat carotid artery model of vascular injury. J Cardiovasc Pharmacol Ther 12 (2007) 237-247
100. Harrington R. Effects of erythropoietin on infarct size and left ventricular remodeling in survivors of large myocardial infarctions (REVEAL). http://www.clinicaltrials.gov/ct2/show/NCT00378352 Accessed July 22, 2009
101. Belonje A., V A., van Gilst W., Anker S., et al. Effects of erythropoietin after an acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III). Am Heart J 155 (2008) 817-822
102. Iwakura A., Luedemann C., Shastry S., et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108 (2003) 3115-3121
103. Strehlow K., Werner N., Berweiler J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107 (2003) 3059-3065
104. Zhao X., Huang L., Yin Y., et al. Autologous endothelial progenitor cells transplantation promoting endothelial recovery in mice. Transpl Int 20 (2007) 712-721
105. Griese D.P., Ehsan A., Melo L.G., et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108 (2003) 2710-2715
106. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 355 (2006) 1274-1277
107. Arnesen H., Lunde K., Aakhus S., et al. Cell therapy in myocardial infarction. Lancet 369 (2007) 2142-2143
108. Bartunek J., Vanderheyden M., Vandekerckhove B., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112 (2005) I178-I183
109. Swanson N., Hogrefe K., Javed Q., et al. Vascular endothelial growth factor (VEGF)-eluting stents: in vitro effects on thrombosis, endothelialization and intimal hyperplasia. J Invasive Cardiol 15 (2003) 688-692
110. Walter D.H., Cejna M., Diaz-Sandoval L., et al. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 110 (2004) 36-45
111. Aoki J., Serruys P.W., van Beusekom H., et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 45 (2005) 1574-1579
112. Duckers H.J., Soullie T., den Heijer P., et al. Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent). EuroIntervention 3 (2007) 350-358
113. Co M., Tay E., Lee C.H., et al. Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up. Am Heart J 155 (2008) 128-132
114. Miglionico M., Patti G., D'Ambrosio A., et al. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients. Catheter Cardiovasc Interv 71 (2008) 600-604
115. de Winter R. Can a Pro-Healing Stent Make a Difference?. Final 12-Month Outcomes From the e-HEALING 5,000 Patient Registry Using the EPC-Coated Genous Stent. Paper presented at Transcatheter Cardiovascular Therapeutics Symposium. San Francisco, CA (September 2009)
116. Cervinka P. A randomized comparison of Genous stent vs chromium-cobalt stent for treatment of ST-Elevation myocardial infarction. A 6-month clinical, angiographic and IVUS follow-up. GENIUS-STEMI trial. Paper presented at: American College of Cardiology 2009 Scientific Sessions and i2 Summit. Orlando, FL (March 2009)
117. Simper D., Stalboerger P.G., Panetta C.J., et al. Smooth muscle progenitor cells in human blood. Circulation 106 (2002) 1199-1204
118. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8 (2002) 403-409
119. Skowasch D., Jabs A., Andrie R., et al. Presence of bone-marrow- and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis. Cardiovasc Res 60 (2003) 684-691